LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

LLY

1,020.69

-0.81%↓

JNJ

243.4

-0.72%↓

ABBV

224.52

-1.08%↓

NVS

165.19

-0.73%↓

MRK

119.22

-2.61%↓

Search

Medpace Holdings Inc

Suletud

SektorTervishoid

444.27 1.82

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

436.35

Max

452.95

Põhinäitajad

By Trading Economics

Sissetulek

24M

135M

Müük

49M

708M

P/E

Sektori keskmine

29.159

108.767

Kasumimarginaal

19.074

Töötajad

6,200

EBITDA

14M

164M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+18.99% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

20. apr 2026

Turustatistika

By TradingEconomics

Turukapital

-3.9B

13B

Eelmine avamishind

442.45

Eelmine sulgemishind

444.27

Uudiste sentiment

By Acuity

50%

50%

167 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Strong Bullish Evidence

Medpace Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

23. okt 2025, 15:15 UTC

Tulu

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Medpace Holdings Inc Prognoos

Hinnasiht

By TipRanks

18.99% tõus

12 kuu keskmine prognoos

Keskmine 521.29 USD  18.99%

Kõrge 582 USD

Madal 419 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Medpace Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

3

Osta

4

Hoia

1

Müü

Tehniline skoor

By Trading Central

300 / 302.88Toetus ja vastupanu

Lühikene perspektiiv

Strong Bullish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Sentiment

By Acuity

167 / 351 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
help-icon Live chat